Related Experiment Video
Updated: Oct 26, 2025

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
Published on: May 12, 2020
Head and Neck Cancer Cell Death due to Mitochondrial Damage Induced by Reactive Oxygen Species from Nonthermal
Chan Oh1, Ho-Ryun Won1,2, Woo Seok Kang3
1Department of Medical Science, Chungnam National University College of Medicine, Daejeon 35015, Republic of Korea.
Abstract:
Mitochondrial targeted therapy is a next-generation therapeutic approach for cancer that is refractory to conventional treatments. Mitochondrial damage caused by the excessive accumulation of reactive oxygen species (ROS) is a principle of mitochondrial targeted therapy. ROS in nonthermal plasma-activated media (NTPAM) are known to mediate anticancer effects in various cancers including head and neck cancer (HNC). However, the signaling mechanism of HNC cell death via NTPAM-induced ROS has not been fully elucidated. This study evaluated the anticancer effects of NTPAM in HNC and investigated the mechanism using transcriptomic analysis. The viability of HNC cells decreased after NTPAM treatment due to enhanced apoptosis. A human fibroblast cell line and three HNC cell lines were profiled by RNA sequencing. In total, 1 610 differentially expressed genes were identified. Pathway analysis showed that activating transcription factor 4 (ATF4) and C/EBP homologous protein (CHOP) were upstream regulators. Mitochondrial damage was induced by NTPAM, which was associated with enhancements of mitochondrial ROS (mtROS) and ATF4/CHOP regulation. These results suggest that NTPAM induces HNC cell death through the upregulation of ATF4/CHOP activity by damaging mitochondria via excessive mtROS accumulation, similar to mitochondrial targeted therapy.
Insights
Nonthermal plasma-activated media induce head and neck cancer cell death by damaging mitochondria and activating the ATF4/CHOP pathway, mimicking mitochondrial targeted therapy.
Area of Science:
- Biochemistry
- Oncology
- Biophysics
Background:
- Mitochondrial targeted therapy offers a novel approach for refractory cancers.
- Excessive reactive oxygen species (ROS) accumulation leading to mitochondrial damage is a key principle in this therapy.
- Nonthermal plasma-activated media (NTPAM) exhibit anticancer effects via ROS, but the precise mechanism in head and neck cancer (HNC) remains unclear.
Purpose of the Study:
- To evaluate the anticancer effects of NTPAM on HNC cells.
- To elucidate the signaling mechanism underlying NTPAM-induced HNC cell death.
- To investigate the role of mitochondrial damage and ROS in this process.
Main Methods:
- Treatment of HNC and fibroblast cell lines with NTPAM.
- Assessment of cell viability and apoptosis.
- Transcriptomic analysis using RNA sequencing.
- Pathway analysis to identify key regulatory factors.
Main Results:
- NTPAM treatment significantly decreased HNC cell viability by inducing apoptosis.
- RNA sequencing identified 1,610 differentially expressed genes.
- Pathway analysis revealed activating transcription factor 4 (ATF4) and C/EBP homologous protein (CHOP) as upstream regulators.
- NTPAM induced mitochondrial damage, characterized by increased mitochondrial ROS (mtROS) and upregulation of the ATF4/CHOP pathway.
Conclusions:
- NTPAM effectively induces HNC cell death through apoptosis.
- The mechanism involves mitochondrial damage mediated by excessive mtROS accumulation.
- Upregulation of the ATF4/CHOP pathway is a critical event in NTPAM-induced HNC cell death, aligning with mitochondrial targeted therapy principles.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mitochondrial Membranes

